Evaluating PMC strategies across perennial and sub-perennial malaria settings using mathematical modelling
Webinar presentation in the Chemoprevention Alliance Research Subgroup, co-presented with Dr Swapnoleena Sen, PhD.
Conference presentations, posters, and invited talks.
Webinar presentation in the Chemoprevention Alliance Research Subgroup, co-presented with Dr Swapnoleena Sen, PhD.


A slide resource on statistical analysis considerations for evidence interpretation and policymaking, including how analytical choices, uncertainty, and presentation of findings can affect policy-relevant conclusions.
Presented during the first meeting of the Global Onchocerciasis Network for Elimination (GONE), in a technical progress session on moxidectin development and business case scenarios. The update was presented with Barbara Roth and Deirdre Hollingsworth and summarised modelling work used to assess where moxidectin, alone or in combination with albendazole, could add value for onchocerciasis and lymphatic filariasis programmes.
The business case considered use cases, health impact, cost-effectiveness, demand, financial viability, and the trade-offs that national programmes, funders, producers, and global partners would need to weigh when considering introduction of moxidectin-based strategies in endemic areas.
View the WHO meeting report here. The session is listed in the Day 2 agenda, with the meeting summary under section 10.3, “Moxidectin development and business case scenarios.”



Related publication here.


First attendance and talk at ASTMH! Click here for the recording (hosted at the MESA website).

